Literature DB >> 11375259

Endothelium-dependent relaxation induced by cathepsin G in porcine pulmonary arteries.

E Glusa1, C Adam.   

Abstract

Serine proteinases elicit profound cellular effects in various tissues mediated by activation of proteinase-activated receptors (PAR). In the present study, we investigated the vascular effects of cathepsin G, a serine proteinase that is present in the azurophil granules of leukocytes and is known to activate several cells that express PARs. In prostaglandin F2alpha (3 microM)-precontracted rings from porcine pulmonary arteries with intact endothelium, cathepsin G caused concentration-dependent relaxant responses (pEC(50)=9.64+/-0.12). The endothelium-dependent relaxant effect of cathepsin G could also be demonstrated in porcine coronary arteries (pEC(50)=9.23+/-0.07). In pulmonary arteries the cathepsin G-induced relaxation was inhibited after blockade of nitric oxide synthesis by L-NAME (200 microM) and was absent in endothelium-denuded vessels. Bradykinin- and cathepsin G-induced relaxant effects were associated with a 5.7 fold and 2.4 fold increase in the concentration of cyclic GMP, respectively. Compared with thrombin and trypsin, which also produced an endothelium-dependent relaxation in pulmonary arteries, cathepsin G was 2.5 and four times more potent, respectively. Cathepsin G caused only small homologous desensitization. In cathepsin G-challenged vessels, thrombin was still able to elicit a relaxant effect. The effects of cathepsin G were blocked by soybean trypsin inhibitor (IC(50)=0.043 microg ml(-1)), suggesting that proteolytic activity is essential for induction of relaxation. Recombinant acetyl-eglin C proved to be a potent inhibitor (IC(50)=0.14 microg ml(-1)) of the cathepsin G effect, whereas neither indomethacin (3 microM) nor the thrombin inhibitor hirudin (5 ATU ml(-1)) elicited any inhibitory activity. Due to their polyanionic structure defibrotide (IC(50)=0.11 microg ml(-1)), heparin (IC(50)=0.48 microg ml(-1)) and suramin (IC(50)=1.85 microg ml(-1)) diminished significantly the relaxation in response to the basic protein cathepsin G. In conclusion, like thrombin and trypsin, cathepsin G is able to induce endothelium-dependent vascular relaxation. It can be released from activated leukocytes at sites of vascular injury and inflammation and, therefore, sufficiently high concentrations might be reached locally in the vascular space to induce vasodilatation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11375259      PMCID: PMC1572797          DOI: 10.1038/sj.bjp.0704089

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

1.  Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases.

Authors:  V Evangelista; G Rajtar; G de Gaetano; J G White; C Cerletti
Journal:  Blood       Date:  1991-06-01       Impact factor: 22.113

2.  Cathepsin G binding to human platelets. Evidence for a specific receptor.

Authors:  M A Selak; J B Smith
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

3.  [On the purification of thrombin preparations].

Authors:  P Walsmann
Journal:  Pharmazie       Date:  1968-07       Impact factor: 1.267

4.  Proteinase-activated receptor 4 (PAR4): action of PAR4-activating peptides in vascular and gastric tissue and lack of cross-reactivity with PAR1 and PAR2.

Authors:  M D Hollenberg; M Saifeddine; B Al-Ani; Y Gui
Journal:  Can J Physiol Pharmacol       Date:  1999-06       Impact factor: 2.273

5.  Enhancement of cathepsin G-induced platelet activation by leukocyte elastase: consequence for the neutrophil-mediated platelet activation.

Authors:  P Renesto; M Chignard
Journal:  Blood       Date:  1993-07-01       Impact factor: 22.113

6.  Human leukocyte cathepsin G and elastase specifically suppress thrombin-induced prostacyclin production in human endothelial cells.

Authors:  B B Weksler; E A Jaffe; M S Brower; O F Cole
Journal:  Blood       Date:  1989-10       Impact factor: 22.113

7.  Heparin inhibits neutrophil-induced platelet activation via cathepsin G.

Authors:  P Ferrer-Lopez; P Renesto; M C Prevost; P Gounon; M Chignard
Journal:  J Lab Clin Med       Date:  1992-03

8.  Inhibition by heparin of platelet activation induced by neutrophil-derived cathepsin G.

Authors:  V Evangelista; P Piccardoni; N Maugeri; G De Gaetano; C Cerletti
Journal:  Eur J Pharmacol       Date:  1992-06-17       Impact factor: 4.432

9.  Defibrotide inhibits platelet activation by cathepsin G released from stimulated polymorphonuclear leukocytes.

Authors:  V Evangelista; P Piccardoni; G de Gaetano; C Cerletti
Journal:  Thromb Haemost       Date:  1992-06-01       Impact factor: 5.249

10.  Cathepsin G is a strong platelet agonist released by neutrophils.

Authors:  M A Selak; M Chignard; J B Smith
Journal:  Biochem J       Date:  1988-04-01       Impact factor: 3.857

View more
  3 in total

1.  Proteinase-activated receptors 1 and 2 and the regulation of porcine coronary artery contractility: a role for distinct tyrosine kinase pathways.

Authors:  Mahmoud El-Daly; Mahmoud Saifeddine; Koichiro Mihara; Rithwik Ramachandran; Christopher R Triggle; Morley D Hollenberg
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 2.  Role of the Purinergic P2Y2 Receptor in Pulmonary Hypertension.

Authors:  Mazen Shihan; Tatyana Novoyatleva; Thilo Lehmeyer; Akylbek Sydykov; Ralph T Schermuly
Journal:  Int J Environ Res Public Health       Date:  2021-10-20       Impact factor: 3.390

3.  Neutrophil cathepsin G, but not elastase, induces aggregation of MCF-7 mammary carcinoma cells by a protease activity-dependent cell-oriented mechanism.

Authors:  Satoru Yui; Yuuki Osawa; Takeo Ichisugi; Riyo Morimoto-Kamata
Journal:  Mediators Inflamm       Date:  2014-04-02       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.